Cargando…

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer

Neuroendocrine differentiation (NED) in colorectal cancer is an indistinct phenomenon and may define a new cancer subtype, especially in the poorly differentiated colorectal cancer (PDCRC). The clinical features of PDCRC with NED remain controversial, thus confusing the implementation of individuali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yue, Xu, Jinghong, Jiao, Yurong, Hu, Yeting, Yi, Chenghao, Li, Qiong, Tong, Zhou, Wang, Xiaowei, Hu, Lifeng, Xiao, Qian, Li, Jun, Ding, Kefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100365/ https://www.ncbi.nlm.nih.gov/pubmed/25093184 http://dx.doi.org/10.1155/2014/789575

Ejemplares similares

Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer
por: Liu, Yue, et al.
Publicado: (2017)

Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
por: Chen, Yue, et al.
Publicado: (2017)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
por: Wang, Haihong, et al.
Publicado: (2020)

Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas
por: Lee, Sun Mi, et al.
Publicado: (2021)

Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
por: Konukiewitz, Björn, et al.
Publicado: (2021)

A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database
por: Kong, Xiangxing, et al.
Publicado: (2018)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

Tumor Differentiation is the Dominant Prognostic Factor for Patients with Colorectal Neuroendocrine Neoplasms with Distant Metastasis
por: Wang, Zhijie, et al.
Publicado: (2022)

Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions
por: Yi, Chenghao, et al.
Publicado: (2016)

Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder
por: Dowd, Katherine, et al.
Publicado: (2017)

Poorly differentiated large-cell neuroendocrine carcinoma of the paranasal sinus
por: Campos, Helder Groenwold, et al.
Publicado: (2018)

A Poorly Differentiated Esophageal Neuroendocrine Carcinoma With Brain Metastasis
por: Swied, Muhammed Yaman, et al.
Publicado: (2023)

Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer
por: Qian, Yucheng, et al.
Publicado: (2021)

Neuroendocrine differentiation: a risk fellow in colorectal cancer
por: Chen, Yue, et al.
Publicado: (2023)

Poorly differentiated mucinous carcinoma with signet ring cells in an ovarian endometriotic cyst: a case report
por: Jiao, Yurong, et al.
Publicado: (2019)

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
por: Pusceddu, Sara, et al.
Publicado: (2018)

ODP020 A Challenging Case of Poorly Differentiated Carcinoma with Neuroendocrine Differentiation and Adrenal Mass
por: Mosquera, Jorge, et al.
Publicado: (2022)

A Minor (<50%) Signet-Ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: A 26-Year Retrospective Study in China
por: Tan, Yinuo, et al.
Publicado: (2015)

Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas
por: Jurescu, Aura, et al.
Publicado: (2022)

Magnifying endoscopic findings of early-stage poorly differentiated colorectal adenocarcinoma: a case report
por: Li, Haiyan, et al.
Publicado: (2022)

Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases
por: Zou, Yi, et al.
Publicado: (2019)

Combination of Irinotecan and a Platinum Agent for Poorly Differentiated Neuroendocrine Carcinomas
por: Ramella Munhoz, Rodrigo, et al.
Publicado: (2013)

Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
por: Apostolidis, Leonidas, et al.
Publicado: (2016)

Primary poorly differentiated small cell type neuroendocrine carcinoma of the hypopharynx
por: Ao, Yin-Jie, et al.
Publicado: (2019)

Surgical palliation in poorly differentiated neuroendocrine carcinoma of the hypopharynx: Case report
por: Fiorini, Francesca Romana, et al.
Publicado: (2021)

Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma
por: Weaver, Jamie M. J., et al.
Publicado: (2023)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Neuroendocrine Differentiation in Sporadic CRC and Hereditary Nonpolyosis Colorectal Cancer
por: Sun, M. H.
Publicado: (2004)

Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer
por: Xu, Dong, et al.
Publicado: (2015)

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis
por: Lamberti, Giuseppe, et al.
Publicado: (2020)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

Poorly Differentiated Large Cell Neuroendocrine Carcinoma of the Colon: A Case Report
por: Felux, Kelsee, et al.
Publicado: (2022)

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

The Disulfiram/Copper Complex Induces Autophagic Cell Death in Colorectal Cancer by Targeting ULK1
por: Hu, Yeting, et al.
Publicado: (2021)

A case of rapidly progressing and poorly differentiated Ip‐type early‐stage colorectal adenocarcinoma
por: Tsubomoto, Atsuko, et al.
Publicado: (2022)

Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma
por: Guo, Jianfei, et al.
Publicado: (2023)

Hormone receptor status may impact the survival benefit of surgery in stage IV breast cancer: a population-based study
por: Tan, Yinuo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rc8sm8ui2766k6ph7nsr92fd3k